AEYE Health Expands Deployment of its Epic EMR-integrated Diabetic Eye Exam Solution
TL/DR –
AEYE Health, a leader in retinal diagnostics, has announced the extended deployment of its integration with the widely used Epic electronic medical record (EMR) platform across the US. The AI platform allows healthcare providers to order diabetic retinopathy (DR) screenings and receive results within one minute, without disrupting existing clinical workflows. This enhanced integration has been deployed across dozens of hospitals and healthcare systems using the Epic platform, and it enables primary care providers, endocrinologists, and diabetes centers to complete on-the-spot diabetic eye exams and receive fully reimbursable billing under CPT code 92229, the first-ever AI-specific reimbursement code in the United States.
AEYE Health Deploys Expanded Integration with Epic EMR for Rapid Diabetic Eye Screenings
AEYE Health, a top-notch organization in retinal diagnostics and the originator of AEYE-DS, the fastest expanding solution for diabetic eye exams in the US, has revealed an expanded nationwide deployment of its integration with the widely-used Epic electronic medical record (EMR) platform.
This comprehensive integration empowers healthcare providers to conduct real-time diabetic retinopathy (DR) screenings in under one minute directly within the Epic EMR, reducing disruptions in clinical workflows. The solution is fully reimbursable under CPT code 92229, the first-ever AI-specific reimbursement code in the US, and supports HEDIS measures.
With this seamless integration, healthcare providers can directly order an AI diabetic retinopathy exam from the patient chart. A single retinal image per eye is captured using a portable camera integrated with AEYE-DS, and results are instantly returned to the patient’s medical record. Full automation of reimbursement code billing is also supported, making the process even more efficient.
“With the exam completed in under one minute and everything being automated, healthcare providers can focus on delivering fast and accurate AI retinal screening at the point of care. Adoption is accelerating rapidly across hospitals and clinics, bringing AEYE-DS to patients nationwide and preventing vision loss,” stated Zack Dvey-Aharon, Co-Founder & CEO of AEYE Health.
AEYE Health is a digital health company offering fully autonomous, AI-based diagnostic screening solutions for retinal imaging. The company’s mission is to make diagnostic screening practical, accurate, and accessible. AEYE-DS is the only FDA-cleared autonomous AI for diabetic retinopathy that requires just one image per eye and is the fastest growing solution for DR screening in the United States.
Contact the AEYE Health Press Team for more information at [email protected].
—
Read More Health & Wellness News ; US News